Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing

AC Chrysostomou, DC Stylianou, A Constantinidou… - Viruses, 2018 - mdpi.com
Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Self-sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs

S Gupta, C Palmer, EM Bik, JP Cardenas… - Frontiers in public …, 2018 - frontiersin.org
In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

[图书][B] Global strategy to accelerate the elimination of cervical cancer as a public health problem

World Health Organization - 2020 - books.google.com
Page 1 GLOBAL STRATEGY TO ACCELERATE THE ELIMINATION OF CERVICAL CANCER
AS A PUBLIC HEALTH PROBLEM Global strategy to accelerate the elimination of cervical …

Resilience of HPV vaccine uptake in Denmark: decline and recovery

PR Hansen, M Schmidtblaicher, NT Brewer - Vaccine, 2020 - Elsevier
Background Immunization programs' resilience to shocks is central to their success, but little
empirical evidence documents resilience in action. We sought to characterize the decline of …

[HTML][HTML] DNA methylation as a triage tool for cervical cancer screening–A meeting report

FR Burdier, B Nedjai, RDM Steenbergen… - Preventive medicine …, 2024 - Elsevier
Introduction DNA methylation is proposed as a novel biomarker able to monitor molecular
events in human papillomavirus (HPV) infection pathophysiology, enabling the distinction …

[HTML][HTML] Knowledge of human papillomavirus and Pap test among Brazilian university students

AD Baptista, CX Simão, VCG Santos… - Revista da Associação …, 2019 - SciELO Brasil
SUMMARY OBJECTIVE: Human papillomavirus (HPV) is the most prevalent sexually
transmitted virus in the world and is associated with an increased risk of cervical cancer. The …

[HTML][HTML] The role of healthcare providers in HPV vaccination programs–a meeting report

A Vorsters, P Bonanni, HC Maltezou, J Yarwood… - Papillomavirus …, 2019 - Elsevier
Abstract The Human Papillomavirus (HPV) Prevention and Control Board convened a
meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers …

Human papillomavirus vaccination in adults: impact, opportunities and challenges–a meeting report

DN Waheed, J Schiller, M Stanley, EL Franco… - BMC proceedings, 2021 - Springer
For more than a decade human papillomavirus (HPV) vaccine have been implemented in
most high-income countries, and more recently also in several low-and middle-income …

[HTML][HTML] An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses–A meeting report

FR Burdier, C Eklund, I Baussano, FC Mariz… - Preventive Medicine …, 2023 - Elsevier
The 12th HPV Prevention and Control meeting was held on June 2–3, 2022, in Antwerp,
Belgium. This technical meeting focused on several topics. This report summarises the …

Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources

W Wang, S Kothari, M Baay, SM Garland… - Expert Review of …, 2022 - Taylor & Francis
Introduction Vaccine effectiveness and impact studies are typically observational, generating
evidence after vaccine launch in a real-world setting. For human papillomavirus (HPV) …